{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:08Z","timestamp":1791011948156,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00467-009-1294-7","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T05:30:17Z","timestamp":1255671017000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Middle-term use of Cinacalcet in paediatric dialysis patients"],"prefix":"10.1007","volume":"25","author":[{"given":"Caroline","family":"Platt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Inward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McGraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Burren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moin A.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,1]]},"reference":[{"key":"1294_CR1","unstructured":"Peritoneal\/heamodialysis clinical practice guidelines for children and adolescents (2007) Module 3. https:\/\/doi.org\/www.bapn.org. Treatment of adults and children with renal failure 3rd edition (2002) https:\/\/doi.org\/www.renal.org\/guidelines (UK Renal Association)"},{"issue":"Suppl 1","key":"1294_CR2","first-page":"S1","volume":"46","author":"National Kidney Foundation","year":"2005","unstructured":"National Kidney Foundation (2005) K\/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46(Suppl 1):S1\u2013S121","journal-title":"Am J Kidney Dis"},{"key":"1294_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","volume":"54","author":"IB Salusky","year":"1998","unstructured":"Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54:907\u2013914","journal-title":"Kidney Int"},{"key":"1294_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","volume":"53","author":"BD Kuizon","year":"1998","unstructured":"Kuizon BD, Goodman WG, J\u00fcppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205\u2013211","journal-title":"Kidney Int"},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ki.1994.380","volume":"46","author":"WG Goodman","year":"1994","unstructured":"Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone disease in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160\u20131166","journal-title":"Kidney Int"},{"key":"1294_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00467-003-1284-0","volume":"18","author":"S Waller","year":"2003","unstructured":"Waller S, Ledermann S, Trompeter R, Van\u2019t Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18:1236\u20131241","journal-title":"Pediatr Nephrol"},{"key":"1294_CR7","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","volume":"12","author":"IB Salusky","year":"2001","unstructured":"Salusky IB, Goodman WG (2001) Adynamic renal osteodystrophy: is there a problem? J Am Soc Nephrol 12:1978\u20131985","journal-title":"J Am Soc Nephrol"},{"key":"1294_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/ki.1989.309","volume":"36","author":"A Lefebvre","year":"1989","unstructured":"Lefebvre A, de Vernejoul MC, Gueris J, Goldfarb B, Graulet AM, Morieux C (1989) Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 36:1112\u20131118","journal-title":"Kidney Int"},{"issue":"Suppl","key":"1294_CR9","first-page":"13","volume":"47","author":"V Tasic","year":"2005","unstructured":"Tasic V (2005) Management of renal osteodystrophy in children. Turk J Pediatr 47(Suppl):13\u201318","journal-title":"Turk J Pediatr"},{"key":"1294_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorous and calcium x phosphate product with mortality risk in chronic haemodialysis patients: a national study. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"1294_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1523-1755.2004.00895.x","volume":"66","author":"D Goldsmith","year":"2004","unstructured":"Goldsmith D, Ritz E, Covic A (2004) Vascular calcification: a stiff challenge for the nephrologist: does preventing bon disease cause arterial disease? Kidney Int 66:1315\u20131333","journal-title":"Kidney Int"},{"key":"1294_CR12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"1294_CR13","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","volume":"85","author":"PC D\u2019Haese","year":"2003","unstructured":"D\u2019Haese PC, Spasovski GB, Sikole A, Hutchinson A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME (2003) A multicenter study on the effects of lanthanum carbonate (Forsenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int 85(Suppl):S73\u2013S78","journal-title":"Kidney Int"},{"key":"1294_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, Schaefer F, Simkova E, Stefanidis CJ, Vande Walle J, Schroder C, Zurowska A, Ekim M (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151\u2013159","journal-title":"Pediatr Nephrol"},{"key":"1294_CR15","first-page":"1703","volume":"9","author":"EM Brown","year":"1994","unstructured":"Brown EM, Pollak M, Riccardi D, Hebert SC (1994) Cloning and characterisation of an extracellular Ca2+ sensing receptor from parathyroid and kidney: new insights into the physiology and pathophysiology of calcium metabolism. Nephrol Dial Transplant 9:1703\u20131706","journal-title":"Nephrol Dial Transplant"},{"key":"1294_CR16","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","volume":"139","author":"YC Li","year":"1998","unstructured":"Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391\u20134396","journal-title":"Endocrinology"},{"key":"1294_CR17","doi-asserted-by":"publisher","first-page":"16754","DOI":"10.1074\/jbc.M310271200","volume":"279","author":"DK Panda","year":"2004","unstructured":"Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D (2004) Inactivation of the 25-hydroxyvitamin D 1 alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279:16754\u201316766","journal-title":"J Biol Chem"},{"key":"1294_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.metabol.2007.11.014","volume":"57","author":"S Sajid-Crockett","year":"2008","unstructured":"Sajid-Crockett S, Singer FR, Hershman JM (2008) Cinacalcet for the treatment of primary hyperparathyroidism. Metabolism 57:517\u2013521","journal-title":"Metabolism"},{"key":"1294_CR19","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DM, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) The calcimimetic Cinacalcet (AMG 073) for the treatment of secondary hyperparathyroidism in haemodialysis patients. N Engl J Med 350:1516\u20131525","journal-title":"N Engl J Med"},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1517\/14656566.9.5.795","volume":"9","author":"A Francisco","year":"2008","unstructured":"Francisco A (2008) New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert Opin Pharmacother 9:795\u2013811","journal-title":"Expert Opin Pharmacother"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","volume":"67","author":"SM Moe","year":"2005","unstructured":"Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drueke TB, Cunningham J, Sherrard DJ, McCary LC, Olsen KA, Turner SA, Martin KJ (2005) Achieving K\/DOQI bone metabolism and disease treatment goals with Cinacalcet HCL. Kidney Int 67:760\u2013771","journal-title":"Kidney Int"},{"key":"1294_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM (2005) Effects of the calcimimetic Cinacalcet HCL on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793\u20131800","journal-title":"Kidney Int"},{"key":"1294_CR23","unstructured":"National Institute for Health and Clinical Excellence (2007) Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. Available at https:\/\/doi.org\/www.nice.org.uk"},{"key":"1294_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1681\/ASN.2004060512","volume":"16","author":"JS Lindberg","year":"2005","unstructured":"Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW (2005) Cinacalcet HCL, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in haemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 16:800\u2013807","journal-title":"J Am Soc Nephrol"},{"key":"1294_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00467-007-0742-5","volume":"23","author":"DM Silverstein","year":"2007","unstructured":"Silverstein DM, Kher KK, Moudgil A, Khurana M, Wilcox J, Moylan K (2007) Cinacalcet is efficacious in paediatric dialysis patients. Pediatr Nephrol 23:1817\u20131822","journal-title":"Pediatr Nephrol"},{"key":"1294_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00467-008-0810-5","volume":"23","author":"J Muscheites","year":"2008","unstructured":"Muscheites J, Wigger M, Drueckler E, Fischer D-C, Kundt G, Haffner D (2008) Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol 23:1823\u20131829","journal-title":"Pediatr Nephrol"},{"key":"1294_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1096\/fj.03-0294fje","volume":"18","author":"S Wu","year":"2004","unstructured":"Wu S, Palese T, Mishra OP, Delivoria-Papadopoulos M, De Luca F (2004) Effects of Ca2+ sensing receptor activation in the growth plate. FASEB J 18:143\u2013145","journal-title":"FASEB J"},{"key":"1294_CR28","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/ndt\/gfn143","volume":"23","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, P\u00e9rez EC, Oh J, Santos F, Geldyyev A, Gross ML, Schaefer F, Schmitt CP (2008) Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia. Nephrol Dial Transplant 23:2761\u20132767","journal-title":"Nephrol Dial Transplant"},{"key":"1294_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00467-003-1290-2","volume":"18","author":"WG Goodman","year":"2003","unstructured":"Goodman WG (2003) Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol 18:1206\u20131210","journal-title":"Pediatr Nephrol"},{"key":"1294_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5414\/CNP68010","volume":"68","author":"JR Sterrett","year":"2007","unstructured":"Sterrett JR, Strom J, Stummvol H-K, Bahner U, Disney A, Soroka SD, Corpier C, Arruda JA, Schwanauer LE, Klassen PS, Olson KA, Block GA (2007) Cinacalcet HCL (Sensipar\/Mimpara) is an effective chronic therapy for haemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 68:10\u201317","journal-title":"Clin Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-009-1294-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1294-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T11:35:20Z","timestamp":1634038520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-009-1294-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s00467-009-1294-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"14 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}